Trump Administration’s Proposed Research Rule Faces Opposition
President Trump’s proposed research rule is stirring controversy. Many are raising concerns over this administration’s plan, claiming it could politicize science funding and jeopardize the U.S.’s leadership in biomedical research. Opposition is coming from patient groups, scientists, bipartisan lawmakers, and pharmaceutical companies. The White House Office of Management and Budget introduced the rule, attracting nearly […]




